HIKAL.NS

Hikal Limited [HIKAL.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

HIKAL.NS Stock Summary

Top 10 Correlated Stocks

HIKAL.NS

In the News

HIKAL.NS Financial details

Company Rating
-
Market Cap
37.26B
Income
716.22M
Revenue
18.03B
Book val./share
-
Cash/share
-
Dividend
1.2
Dividend %
0.4%
Employees
2.14K
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
44.84
Forward P/E
-
PEG
-8.1
P/S
1.94
P/B
3.21
P/C
-
P/FCF
-
Quick Ratio
0.63
Current Ratio
1.28
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
5.81
EPS next Y
-
EPS next Q
-
EPS this Y
-51.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.32%
Revenue last 5Y
4.77%
Revenue Q/Q
3.79%
EPS Q/Q
28.43%
-
-
-
-
SMA20
0.76%
SMA50
13.02%
SMA100
-0.13%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
14%
ROC
0.1%
Gross Margin
50%
Oper. Margin
9%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
250.1-329.0
52W High
+17.86%
52W Low
+55.1%
RSI
44.2
Rel Volume
1.01
Avg Volume
224.61K
Volume
225.84K
Perf Week
-8.51%
Perf Month
-0.76%
Perf Quarter
1.13%
Perf Half Y
8.7%
-
-
-
-
Beta
1.143
-
-
Volatility
10.4%, 13.65%
Prev Close
-3.15%
Price
387.75
Change
-3.28%

HIKAL.NS Financial Performance

HIKAL.NS Dividend History

HIKAL.NS Frequently Asked Questions

What is Hikal Limited stock symbol ?

Hikal Limited is a IN stock and trading under the symbol HIKAL.NS

What is Hikal Limited stock quote today ?

Hikal Limited stock price is $387.75 today.

Is Hikal Limited stock public?

Yes, Hikal Limited is a publicly traded company.

Something similar

Top by Market Cap
VFINX
JPM
VTI
GOOG
0YXG.L
Same Sector
0QGJ.L
BLFS
TEVA.TA
ETNB
GNOW
Top Correlated Stocks
INDHOTEL.NS
KOPRAN.NS
PGEL.NS
ASHAPURMIN.NS
KIRLOSENG.NS
Similar Market Cap
CGEMY
3413.TW
WN.TO
CBG-R.BK
ENI.DE

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 224.61K
  • Market Capitalization 37.26B
  • Employee 2.14K
  • CEO Mr. Jai Vishwanath Hiremath
  • Headquarters Navi Mumbai,IN
  • IPO Date 2002-07-01
  • Website https://www.hikal.com

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.